Santa Monica, CA May 20, 2021 -- GumGum, a global technology and media company specializing in contextual intelligence, today announced their partnership with DeepIntent, the leading healthcare marketing technology company built purposefully to influence patient health and business outcomes.
Pharma is one of the most challenging verticals to navigate, with marketers having to comply with restrictions and strict regulations. This partnership will give advertisers the ability to pair DeepIntent’s unique data and technology with GumGum’s precise contextual capabilities and unique ad formats allowing for a more streamlined workflow and to boost campaign performance and reach key audiences specific to pharma and healthcare.
“We’ve heard from our healthcare clients several times regarding how challenging it is to place successful campaigns while adhering to industry regulations. We are excited to be partnering with DeepIntent, to give our mutual clients a streamlined path to buying and managing pharma-specific media in one place and have access to additional HIPAA compliant targeting options,” said Adam Schenkel, SVP Global Commercial Development, GumGum.
In addition to providing a streamlined workflow for pharma media placements, GumGum will also offer DeepIntent’s clients additional targeting options to use in combination with their first party data. As data privacy regulations continue to grow and major players like Google move away from the cookie, using contextual targeting and first-party data will be a critical element for advertisers to continue to ensure the effectiveness of their campaigns.
“We are excited to offer our clients the opportunity to use GumGum’s unique ad formats to bring their campaigns and targeting capabilities to the next level. With the expertise of both DeepIntent and GumGum, our mutual clients will be able to streamline their campaign placement process and ensure that each campaign is effective and engaging.” said Greg Smith, CRO DeepIntent.
“The integration between GumGum and DeepIntent allows us to leverage their unique and innovative rich media format strengths and keep our planning and buying process streamlined, while ensuring our clients’ HCP and patient campaigns have the scale and critical targeting criteria in place to maximize effectiveness and efficiencies,” said Jacob Lustig, VP, Programmatic Platforms and Media Innovations, Klick Health.
GumGum has expanded their healthcare vertical DSP integrations over the past year with - DeepIntent being our newest integration. For over a decade, GumGum has been the leader in contextual intelligence through its Verity™ offering, which incorporates leading computer vision and natural language processing technology to help advertisers the ideal content to place ads.
For more information please reach out to email@example.com.
GumGum is a global technology and media company specializing in contextual intelligence. For over a decade, we have applied our proven machine learning expertise to extract value from digital content for the advertising and sports industries. Our proprietary contextual intelligence engine uses computer vision and natural language processing technologies to scan text, images and videos when evaluating digital content. Combining our contextual advertising intelligence with proprietary high-impact ad formats, GumGum’s advertising solutions deliver industry leading efficiency, accuracy and performance.
Conceived by former Memorial Sloan Kettering data scientists, DeepIntent connects healthcare companies with patients and providers across every device through unique data, media partnerships, and integrations. From campaign planning to audience targeting to measuring and optimization, DeepIntent is proven to increase script lift while improving patients’ quality of life. Its Healthcare Marketing Platform empowers marketers at seven of the top ten pharmaceutical companies and leading healthcare advertising agencies to positively influence health and business outcomes. For more information, visit DeepIntent.com.